These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23786396)

  • 1. Defective CD8+CD28+ regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy.
    Ceeraz S; Hall C; Choy EH; Spencer J; Corrigall VM
    Clin Exp Immunol; 2013 Oct; 174(1):18-26. PubMed ID: 23786396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
    Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
    Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
    Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets.
    Li H; Wang W; Wang G; Hou Y; Xu F; Liu R; Wang F; Xue J; Hu T; Luan X
    Cytotherapy; 2015 Nov; 17(11):1560-71. PubMed ID: 26432559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.
    van Amelsfort JM; van Roon JA; Noordegraaf M; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
    Arthritis Rheum; 2007 Mar; 56(3):732-42. PubMed ID: 17328044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells.
    Benito-Miguel M; García-Carmona Y; Balsa A; Pérez de Ayala C; Cobo-Ibáñez T; Martín-Mola E; Miranda-Carús ME
    J Immunol; 2009 Dec; 183(12):8268-79. PubMed ID: 20007590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
    Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
    Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg Cells in Patients With Chronic Rheumatoid Arthritis.
    Walter GJ; Fleskens V; Frederiksen KS; Rajasekhar M; Menon B; Gerwien JG; Evans HG; Taams LS
    Arthritis Rheumatol; 2016 Jan; 68(1):103-16. PubMed ID: 26314565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Numerical and functional defects in CD8
    Li H; Hao Y; Zhang D; Liu W; Li Y; Lyu M; Fu R; Xue F; Liu X; Yang R
    Br J Haematol; 2017 Jul; 178(2):292-301. PubMed ID: 28466476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
    Wang H; Daniel V; Sadeghi M; Opelz G
    Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
    Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
    Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.
    Cribbs AP; Kennedy A; Penn H; Amjadi P; Green P; Read JE; Brennan F; Gregory B; Williams RO
    Arthritis Rheumatol; 2015 May; 67(5):1182-92. PubMed ID: 25604080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.
    Zhang S; Ke X; Zeng S; Wu M; Lou J; Wu L; Huang P; Huang L; Wang F; Pan S
    Cell Mol Immunol; 2015 Sep; 12(5):580-91. PubMed ID: 26166762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation.
    Mikami N; Kawakami R; Chen KY; Sugimoto A; Ohkura N; Sakaguchi S
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12258-12268. PubMed ID: 32414925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response.
    Stoop JN; Woltman AM; Biesta PJ; Kusters JG; Kuipers EJ; Janssen HL; van der Molen RG
    Hepatology; 2007 Sep; 46(3):699-705. PubMed ID: 17654744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.
    Picchianti Diamanti A; Rosado MM; Scarsella M; Germano V; Giorda E; Cascioli S; Laganà B; D'Amelio R; Carsetti R
    Clin Exp Immunol; 2014 Sep; 177(3):630-40. PubMed ID: 24773026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of CD80/CD86-CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells.
    Shi Z; Rifa'i M; Lee YH; Shiku H; Isobe K; Suzuki H
    Immunology; 2008 May; 124(1):121-8. PubMed ID: 18205792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells.
    Hilchey SP; De A; Rimsza LM; Bankert RB; Bernstein SH
    J Immunol; 2007 Apr; 178(7):4051-61. PubMed ID: 17371959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma.
    Meloni F; Morosini M; Solari N; Passadore I; Nascimbene C; Novo M; Ferrari M; Cosentino M; Marino F; Pozzi E; Fietta AM
    Hum Immunol; 2006; 67(1-2):1-12. PubMed ID: 16698419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.